已收盘 08-21 16:00:00 美东时间
-0.020
-0.04%
今日重点评级关注:HC Wainwright & Co.:维持Greenwich LifeSciences"买入"评级,目标价从50美元升至69美元;高盛:维持Taysha Gene Therapies"买入"评级,目标价从11美元升至13美元
07-22 11:35
Piper Sandler analyst Alexander Goldfarb maintains Innovative Ind Props (NYSE:IIPR) with a Underweight and raises the price target from $45 to $51.
07-22 01:37
新浪财经ESG评级中心提供包括资讯、报告、培训、咨询等在内的14项ESG服务,助力上市公司传播ESG理念,提升ESG可持续发展表现。点击查看【 ESG评级中...
07-09 07:00
Innovative Ind Props (NYSE:IIPR) held its first-quarter earnings conference cal...
05-06 00:39
Innovative Industrial Properties shares are trading higher after the company re...
05-05 23:32
Innovative Ind Props (NYSE:IIPR) reported quarterly earnings of $1.88 per share which beat the analyst consensus estimate of $1.79 by 5.03 percent. This is a 3.09 percent decrease over earnings of $1.94 per share from
05-05 04:31
Companies Reporting Before The Bell • Pulse Biosciences (NASDAQ:PLSE) is likely...
05-04 19:11